Supplement to The American Journal of Cardiology October 18, 2001 vol. 88 (8A)
• A Symposium: Interventions in cardiology: Focus on lipid management in acute and long-term settings
Exciting new data have emerged on the relative roles of medical therapy and percutaneous coronary intervention (PCI) in patients with acute coronary syndromes (ACS). This supplement summarizes and discusses these new data and their implications, with a particular focus on the vascular biology of high-risk coronary lesions and the particular challenges of risk reduction in ACS. In this regard, the multifactorial nature of the underlying vascular biology of the unstable coronary plaque requires consideration of antiplatelet, antithrombin, and anti-ischemic therapies, as well as PCI.